International Scientific Committee

• Vita Dolžan, chair (Faculty of Medicine, University of Ljubljana, Slovenia; ESPT, SafePolyMed, PharmGenHub)
• Magnus Ingelman-Sundberg (Karolinska Institutet, Stockholm, Sweden)
• William Newman (Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, United Kingdom; ESHG)
• Cristina Rodriguez-Antona (Spanish National Cancer Research Centre, Madrid, Spain)
• Ron van Schaik (Erasmus Medical Center, Erasmus University Medical Centre, Rotterdam, The Netherlands; ESPT)
• Julia C. Stingl (Heidelberg University Hospital, Germany; SafePolyMed)

Local organizing Committee

• Vita Dolžan, chair
• Katja Goričar
• Tanja Blagus
• David Vogrinc
• Teja Muha

Endorsed and supported by

European Society of Human Genetics - ESHG

European Society of Pharmacogenomics and Personalised Therapy - ESPT

ARIS programme P1-0170: Molecular mechanisms of regulation of cellular processes related to some human diseases

HORIZON-HLTH-2021-CARE-05 project: Improving Safety in Polymedication by Managing Drug-Drug-Gene Interactions - SafePolyMed (GA No. 101057639)

HORIZON-WIDERA-2021-ACCESS-02 project: Pharmacogenomics Hub in a strengthened IMGGE - PharmGenHUB (GA No. 101059870)

UL/ARIS 2024-2025 big interdisciplinary project: Personalizirana medicina za zdravo staranje (Personalized Medicine for Healthy Ageing) – PerMedZaSe

Organizational support

ANTANA PCO